Fasting Mimicking Diet for Ovarian Cancer
Trial Summary
What is the purpose of this trial?
This study evaluates how lifestyle modifications that may be made to manage chemotherapy side effects in patients with gynecologic malignancies.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but you cannot participate if you take daily medications that cannot be safely taken without food.
What data supports the effectiveness of the Fasting Mimicking Diet treatment for ovarian cancer?
Is the fasting mimicking diet generally safe for humans?
How does the fasting mimicking diet treatment differ from other treatments for ovarian cancer?
The fasting mimicking diet (FMD) is unique because it involves cycles of low-calorie, low-carbohydrate, and low-protein intake, which can enhance the effects of standard cancer treatments like chemotherapy. Unlike traditional treatments that focus solely on medication, FMD works by mimicking the effects of fasting, potentially improving the body's response to cancer therapies.12367
Research Team
Jonathan Boone
Principal Investigator
The University of Tennessee Medical Center
Eligibility Criteria
This trial is for patients with gynecologic cancers such as ovarian cancer, who are undergoing chemotherapy. It's designed to see if a special diet that mimics fasting can help manage the side effects of their treatment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive chemotherapy with or without a fasting mimicking diet for 21 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Fasting Mimicking Diet
Find a Clinic Near You
Who Is Running the Clinical Trial?
L-Nutra Inc
Lead Sponsor
University of Tennessee Medical Center
Collaborator